KOLTEPATIL.NS(KOLTEPATIL.NS)
KOLTEPATIL.NS
$436.85—Stale · unknown old
NSE • Last print unknown ago
$436.85—Stale · unknown old
No analyst ratings available
No analyst price targets available for KOLTEPATIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $19.35B | $21.97B |
| Low | $17.03B | $16.01B |
| High | $21.68B | $28.21B |
| EBITDA Avg | $3.00B | $4.22B |
| Low | $2.97B | $3.42B |
| High | $3.49B | $4.69B |
| EBIT Avg | $2.76B | $3.91B |
| Low | $2.73B | $3.11B |
| High | $3.26B | $4.38B |
| Net Income Avg | $1.68B | $2.55B |
| Low | $1.66B | $1.94B |
| High | $2.05B | $2.91B |
| EPS Avg | $21.65 | $29.90 |
| Low | $19.34 | $22.62 |
| High | $23.96 | $33.93 |
| Analysts (Rev / EPS) | 2 / 1 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $1.70B | $2.90B | $3.24B |
| Low | $1.70B | $2.90B | $3.24B |
| High | $1.70B | $2.90B | $3.24B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |